Form 4 for PG Procter & Gamble
Accepted 2024-05-17 00:00:00 ET · period of report 2024-05-16 · accession 0001127602-24-015803 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-17 | 2024-05-16 | PG | Aguilar Moses Victor Javier | Chf Rsch, Dev, Innov Off | M - OptEx | $85.13 | +9,149 | 22.1K | +71% | +$778.9K |
| D | 2024-05-17 | 2024-05-16 | PG | Aguilar Moses Victor Javier | Chf Rsch, Dev, Innov Off | S - Sale+OE | $167.72 | -9,149 | 12.9K | -41% | -$1.53M |
| D | 2024-05-17 | 2024-02-15 | PG | Aguilar Moses Victor Javier | Chf Rsch, Dev, Innov Off | A - Grant | $0.00 | +8.12 | 45.41 | +22% | $0 |
| D | 2024-05-17 | 2024-05-16 | PG | Aguilar Moses Victor Javier | Chf Rsch, Dev, Innov Off | M - OptEx | $0.00 | -9,149 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-16 | M | A | 9,149 | $85.13 | 22,077.59 | D | — | — | (F1) Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock and shares acquired through the issuer's dividend reinvestment plan. |
| 2 | Common | Common Stock | 2024-05-16 | S | D | 9,149 | $167.72 | 12,928.59 | D | — | — | (F2) Weighted average price of the shares sold. The price range was $167.69 to $167.755. Full information regarding the number of shares sold at each separate price available upon request. |
| 3 | Derivative | Restricted Stock Units | 2024-02-15 | A | A | 8.12 | $0.00 | 45.41 | D | — · — to — | 8.12 Common Stock | (F4) Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. (F5) These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-05-16 | M | D | 9,149 | $0.00 | 0 | D | $85.13 · 2018-02-27 to 2025-02-27 | 9,149 Common Stock |